Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Adzenys price, strengths & recalls

Brand of amphetamine (generic)

Pharmacies pay $575.79 for 30 tablets of Adzenys 12.5 mg (24 hr) extended-release tablet this week, and from $574.23 to $576.07 across its 6 priced strengths and forms. The generic, amphetamine, costs pharmacies from $13.55. It is in shortage (in shortage). It has 14 recalls on record, none ongoing. Its official label last changed on September 28, 2026.

In shortageBrand
Pharmacies pay$575.79for 30 tablets of 12.5 mg (24 hr) extended-release tablet-0.1% in 4 weeks
Fair cash price
$672.66
Strengths
6
Makers
1
Updated
Nov 11

Adzenys price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
3.1 mg (24 hr) extended-release tablet Brand$19.20$576.07 / 30 tabletsNo change-0.1%
6.3 mg (24 hr) extended-release tablet Brand$19.14$574.23 / 30 tablets-0.4%-0.7%
9.4 mg (24 hr) extended-release tablet Brand$19.17$575.17 / 30 tablets-0.1%-0.4%
12.5 mg (24 hr) extended-release tablet Brand$19.19$575.79 / 30 tablets-0.1%-0.3%
15.7 mg (24 hr) extended-release tablet Brand$19.16$574.72 / 30 tabletsNo change-0.6%
18.8 mg (24 hr) extended-release tablet Brand$19.19$575.66 / 30 tablets-0.1%-0.6%

The lowest cost per tablet is 6.3 mg (24 hr) extended-release tablet at $19.14. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Adzenys vs generic amphetamine

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
3.1 mg (24 hr) extended-release tablet$576.07$480.861.2x
6.3 mg (24 hr) extended-release tablet$574.23$478.171.2x
9.4 mg (24 hr) extended-release tablet$575.17$482.181.2x
12.5 mg (24 hr) extended-release tablet$575.79$467.401.2x
15.7 mg (24 hr) extended-release tablet$574.72$475.701.2x
18.8 mg (24 hr) extended-release tablet$575.66$455.221.3x
GenericAmphetamine prices

Supply status: shortages & recalls

In shortage2 products are short or being discontinued
No ongoing recalls14 recalls on record

Shortages

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg...Lannett Company, Inc. · Available · Updated Nov 2, 2026
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg...Lannett Company, Inc. · Available · Updated Nov 2, 2026

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 14 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for adzenys? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 28, 2026
Version16 of 15
EffectiveMay 13, 2026
Read the label

These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960

This drug has a boxed warning

WARNING: ABUSE, MISUSE AND ADDICTION

ADZENYS XR-ODT has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including ADZENYS XR-ODT, can result in overdose and death

[see Overdosage (10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.

Before prescribing ADZENYS XR-ODT, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout ADZENYS XR-ODT treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction

[see Warnings and Precautions (5.1), Drug Abuse and Dependence (9.2)].

See full prescribing information for complete boxed warning.

ADZENYS XR-ODT has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including ADZENYS XR-ODT, can result in overdose and death (5.1, 9.2, 10):

Before prescribing ADZENYS XR-ODT, assess each patient's risk for abuse, misuse, and addiction.

Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.

Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.

Recent major changes (as listed on the label)

Indications and Usage (

1) 09/2025

Warnings and Precautions (

5.5) 09/2025

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA204326 · Neos Theraps
First approved
January 27, 2016 (10 years ago)
Latest approved change
September 23, 2025
Approved label
PDF, Dec 12, 2025
Generic makers
8 approved generic applications on the market
Last patent listed
June 28, 2032

Adzenys questions

How much does adzenys cost without insurance?

Pharmacies pay about $575.79 for 30 tablets of adzenys 12.5 mg (24 hr) extended-release tablet ($19.19 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $672.66. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Adzenys?

Yes: amphetamine. Pharmacies pay from $13.55 for it. Compare amphetamine prices.

Is adzenys in shortage?

Yes. 2 products are listed as in shortage or being discontinued (in shortage). See which ones.

Has adzenys been recalled?

14 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the adzenys label last change?

The official label was last updated on September 28, 2026 (version 16). See what changed.

Talk about adzenys

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.